Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA)

This study has been completed.
Commonwealth Medical Clinic
Institut de Recherches Cliniques de Montreal
Clinique des maladies lipidiques de Québec
Centre de médecine genique communautaire
Omnispec clinical research Inc
Manna Research
St Jerome Medical Research Inc.
Royal Victoria Hospital, Canada
Hotel Dieu Hospital
St Michael's Hospital Health Center
Cambridge Cardiac Care Centre
Maritime Research Center
Rhodin Recherche Clinique
Queen Health Sciences Centre
First Line Medical Ltd
Diabetes Research, Vancouver General Hosp
Allin Clinic
St Paul's Hospital Healthy Heart Clinical Trial
The Clinical Trials Centre
Invascor Clinical Research
MSHJ Research Associates
Dr.Kim W Tan
Information provided by:
Montreal Heart Institute Identifier:
First received: August 21, 2007
Last updated: June 18, 2010
Last verified: January 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2008
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)